{
    "eid": "2-s2.0-85144677545",
    "title": "Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "cervical cancer",
        "human papillomavirus",
        "immunotherapy",
        "plant-made pharmaceuticals",
        "recombinant drugs",
        "therapeutic vaccine"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Ashwini Malla",
        "Christine Joy I. Bulaon",
        "Waranyoo Phoolcharoen",
        "Natacha Phoolcharoen"
    ],
    "citedby-count": 4,
    "ref-count": 100,
    "ref-list": [
        "Cancer development, progression, and therapy: An epigenetic overview",
        "Economic Perspective of Cancer Care and Its Consequences for Vulnerable Groups",
        "The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment",
        "Cervical cancer: A global health crisis",
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Estimates of incidence and mortality of cervical cancer in 2018: A worldwide analysis",
        "Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world",
        "Plant-derived vaccines",
        "Effective screening programmes for cervical cancer in low- and middle-income developing countries",
        "The role of surgery in locally advanced carcinoma of cervix after sub-optimal chemoradiation: Indian scenario",
        "The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy",
        "Mortality impact of achieving WHO cervical cancer elimination targets: A comparative modelling analysis in 78 low-income and lower-middle-income countries",
        "Human papillomavirus: Gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies",
        "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide",
        "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update",
        "The estimated lifetime probability of acquiring human papillomavirus in the United States",
        "Cervical Cancer: An Overview of Pathophysiology and Management",
        "Chapter 1: Human Papillomavirus and Cervical Cancer\u2014Burden and Assessment of Causality",
        "Management of adolescents who have abnormal cytology and histology",
        "Prevention strategies of cervical cancer in the HPV vaccine era",
        "Epidemiologic classification of human papillomavirus types associated with cervical cancer",
        "Mechanisms of human papillomavirus-induced oncogenesis",
        "Human papillomavirus testing in the prevention of cervical cancer",
        "Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer",
        "Global estimates of human papillomavirus vaccination coverage by region and income level: A pooled analysis",
        "Bacterial and viral vectors as vaccine delivery vehicles for breast cancer therapy",
        "Understanding the tumor immune microenvironment (TIME) for effective therapy",
        "Immune checkpoint signaling and cancer immunotherapy",
        "Next generation of immune checkpoint therapy in cancer: New developments and challenges",
        "The Immune Landscape of Cancer",
        "Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data",
        "Immune checkpoint: The novel target for antitumor therapy",
        "Functions of Immune Checkpoint Molecules Beyond Immune Evasion",
        "Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status",
        "Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas",
        "Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers",
        "PD-1/PD-L1 Inhibitors in Cervical Cancer",
        "Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer",
        "Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial",
        "Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study",
        "Expression of Vascular Endothelial Growth Factor in Adenocarcinomas of the Uterine Cervix and Its Relation to Angiogenesis and p53 and c-erbB-2 Protein Expression",
        "Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status",
        "Oncogenes and tumor angiogenesis: The HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner",
        "Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors",
        "Circulating vascular endothelial growth factors and their soluble receptors in pre-invasive, invasive and recurrent cervical cancer",
        "Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix",
        "Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: A gynecologic oncology group study",
        "Bevacizumab combination therapy in recurrent, platinum-refractory, epithelial ovarian carcinoma: A retrospective analysis",
        "Monoclonal antibodies in gynecological cancer: A critical point of view",
        "Bevacizumab for advanced cervical cancer: Final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)",
        "Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?",
        "Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma",
        "Efficacy and Safety of Immunotherapy for Cervical Cancer-A Systematic Review of Clinical Trials",
        "Advances in immunotherapy for cervical cancer: Recent developments and future directions",
        "Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development",
        "Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro",
        "Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates",
        "Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants",
        "Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age",
        "Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity",
        "A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics",
        "Efficacy and Safety of a Recombinant Plant-Based Adjuvanted COVID-19 Vaccine",
        "Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants",
        "Chapter 12\u2014SARS-CoV-2 vaccines: Current trends and prospects of developing plant-derived vaccines",
        "Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production",
        "The potential of plants for the production and delivery of human papillomavirus vaccines",
        "Plant-Made Vaccines in the Fight Against Cancer",
        "Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles",
        "Plant-derived Human Papillomavirus 16 E7 Oncoprotein Induces Immune Response and Specific Tumor Protection1",
        "Exploiting the Plant Secretory Pathway to Improve the Anticancer Activity of a Plant-Derived HPV16 E7 Vaccine",
        "Immunomodulatory activity of a plant extract containing human papillomavirus 16-E7 protein in human monocyte-derived dendritic cells",
        "Potato Virus X Coat Protein Fusion to Human Papillomavirus 16 E7 Oncoprotein Enhance Antigen Stability and Accumulation in Tobacco Chloroplast",
        "Anti-cancer activity of plant-produced HPV16 E7 vaccine",
        "An E7-based therapeutic vaccine protects mice against HPV16 associated cancer",
        "Extraction, purification and characterization of the plant-produced HPV16 subunit vaccine candidate E7 GGG",
        "Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice",
        "Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana",
        "LALF32-51-E7, a HPV-16 therapeutic vaccine candidate, forms protein body-like structures when expressed in Nicotiana benthamiana leaves",
        "Bioproduction of a Therapeutic Vaccine Against Human Papillomavirus in Tomato Hairy Root Cultures",
        "Oral Immunogenicity of Human Papillomavirus-Like Particles Expressed in Potato",
        "Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum",
        "Plant-Produced Cottontail Rabbit Papillomavirus L1 Protein Protects against Tumor Challenge: A Proof-of-Concept Study",
        "Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants",
        "Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi",
        "Expression of Human Papillomavirus Type 16 L1 Protein in Transgenic Tobacco Plants",
        "Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector",
        "Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: Comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization",
        "Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco",
        "Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic",
        "High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector",
        "Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves",
        "An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice",
        "Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model",
        "Transient expression of HPV16 E7 peptide (aa 44\u201360) and HPV16 L2 peptide (aa 108\u2013120) on chimeric potyvirus-like particles using Potato virus X-based vector",
        "Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: A step towards cost-effective second-generation vaccines",
        "Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants",
        "Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants",
        "Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras",
        "Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity",
        "Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "117011815",
            "affilname": "Ltd.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/117011815",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Fund",
        "Chulalongkorn University"
    ]
}